Barth S - Search Results

1

Metalloproteinase inhibition augments antitumor efficacy of the anti-CD30 immunotoxin Ki-3(scFv)-ETA' against human lymphomas in vivo.

Matthey B, Borchmann P, Schnell R, Tawadros S, Lange H, Huhn M, Klimka A, Tur MK, Barth S, Engert A, Hansen HP. Matthey B, et al. Among authors: barth s. Int J Cancer. 2004 Sep 10;111(4):568-74. doi: 10.1002/ijc.20278. Int J Cancer. 2004. PMID: 15239135

2

Inhibition of metalloproteinases enhances the internalization of anti-CD30 antibody Ki-3 and the cytotoxic activity of Ki-3 immunotoxin.

Hansen HP, Matthey B, Barth S, Kisseleva T, Mokros T, Davies SJ, Beckett RP, Foelster-Holst R, Lange HH, Engert A, Lemke H. Hansen HP, et al. Among authors: barth s. Int J Cancer. 2002 Mar 10;98(2):210-5. doi: 10.1002/ijc.10182. Int J Cancer. 2002. PMID: 11857410

3

A novel approach for immunization, screening and characterization of selected scFv libraries using membrane fractions of tumor cells.

Tur MK, Rothe A, Huhn M, Goerres U, Klimka A, Stöcker M, Engert A, Fischer R, Finner R, Barth S. Tur MK, et al. Among authors: barth s. Int J Mol Med. 2003 Apr;11(4):523-7. Int J Mol Med. 2003. PMID: 12632108

4

Secretion of functional anti-CD30-angiogenin immunotoxins into the supernatant of transfected 293T-cells.

Stöcker M, Tur MK, Sasse S, Krüssmann A, Barth S, Engert A. Stöcker M, et al. Among authors: barth s. Protein Expr Purif. 2003 Apr;28(2):211-9. doi: 10.1016/s1046-5928(02)00709-x. Protein Expr Purif. 2003. PMID: 12699683

5

The recombinant anti-EGF receptor immunotoxin 425(scFv)-ETA' suppresses growth of a highly metastatic pancreatic carcinoma cell line.

Bruell D, Stöcker M, Huhn M, Redding N, Küpper M, Schumacher P, Paetz A, Bruns CJ, Haisma HJ, Fischer R, Finnern R, Barth S. Bruell D, et al. Among authors: barth s. Int J Oncol. 2003 Oct;23(4):1179-86. doi: 10.3892/ijo.23.4.1179. Int J Oncol. 2003. PMID: 12964002

6

Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells.

Tur MK, Huhn M, Thepen T, Stöcker M, Krohn R, Vogel S, Jost E, Osieka R, van de Winkel JG, Fischer R, Finnern R, Barth S. Tur MK, et al. Among authors: barth s. Cancer Res. 2003 Dec 1;63(23):8414-9. Cancer Res. 2003. PMID: 14679004

7

Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells.

Heuser C, Guhlke S, Matthies A, Bender H, Barth S, Diehl V, Abken H, Hombach A. Heuser C, et al. Among authors: barth s. Int J Cancer. 2004 Jun 20;110(3):386-94. doi: 10.1002/ijc.20098. Int J Cancer. 2004. PMID: 15095304

8

Measurement of antibody-membrane interactions by surface plasmon resonance.

Klimka A, Tur MK, Huhn M, Bierfreund U, Terrada E, Fischer R, Finnern R, Barth S. Klimka A, et al. Among authors: barth s. Int J Mol Med. 2004 Oct;14(4):765-8. Int J Mol Med. 2004. PMID: 15375615

9

Recombinant anti-EGFR immunotoxin 425(scFv)-ETA' demonstrates anti-tumor activity against disseminated human pancreatic cancer in nude mice.

Bruell D, Bruns CJ, Yezhelyev M, Huhn M, Müller J, Ischenko I, Fischer R, Finnern R, Jauch KW, Barth S. Bruell D, et al. Among authors: barth s. Int J Mol Med. 2005 Feb;15(2):305-13. Int J Mol Med. 2005. PMID: 15647848

10

Generation of human antibody fragments against Streptococcus mutans using a phage display chain shuffling approach.

Kuepper MB, Huhn M, Spiegel H, Ma JK, Barth S, Fischer R, Finnern R. Kuepper MB, et al. Among authors: barth s. BMC Biotechnol. 2005 Jan 25;5:4. doi: 10.1186/1472-6750-5-4. BMC Biotechnol. 2005. PMID: 15667665 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

667 results

Search Page

Filters